Search results

Richmond Research Institute asks the question, 'Can a second booster dose be delayed in patients who have COVID-19?'

globally. In the UK, two vaccines (BNT162b2-mRNA produced by Pfizer, and ChAdOx-1-S produced by Oxford-AstraZeneca) have been licensed to date, and their administration is prioritised according to individual risk. This publication examines a longitudinal

COVID-19 Testing - Richmond Research Institute

and Pfizer/BioNTech vaccines generate antibodies to the spike protein and we want to be able to detect both natural and vaccine generated immunity. Our latest publication. shows that individuals who have been infected with SARS-CoV-2 previously develop

Home video

to save and improve lives. Do post-COVID-19 patients need a second dose of vaccine? Individuals who were previously infected produced significantly more antibodies, more rapidly. This data could inform prioritisation of vaccine administration. COVID-19

Richmond Research Institute - research to save and improve lives

previously infected produced significantly more antibodies, more rapidly. This information could inform the prioritisation of vaccine administration. Watch the video below to learn more. The Institute has consolidated a stream of academic research projects

Richmond Research Institute collaborates with the following organisations:

richmond research institute

We have a track record in conducting clinical research and have published over 250 research pieces.


We collaborate with outstanding academic talent and partners worldwide.


Our academic research helps improve lives and strengthens scientific insights.